恩帕吉菲
医学
心肌梗塞
心力衰竭
内科学
心脏病学
疾病
肾脏疾病
重症监护医学
2型糖尿病
糖尿病
内分泌学
作者
Javed Butler,W. Schuyler Jones,Jacob A. Udell,Stefan D. Anker,Mark C. Petrie,Josephine Harrington,Michaela Mattheus,Isabella Zwiener,Offer Amir,M. Cecilia Bahit,Johann Bauersachs,Antoni Bayés‐Genís,Yundai Chen,Vijay Chopra,Gemma A. Figtree,Junbo Ge,Shaun G. Goodman,Nina Gotcheva,Shinya Goto,Tomasz Gąsior
标识
DOI：10.1056/nejmoa2314051
摘要
Among patients at increased risk for heart failure after acute myocardial infarction, treatment with empagliflozin did not lead to a significantly lower risk of a first hospitalization for heart failure or death from any cause than placebo. (Funded by Boehringer Ingelheim and Eli Lilly; EMPACT-MI ClinicalTrials.gov number, NCT04509674.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
潇洒的惋清
愉快的真
Criminology34
ousqki
OK
Oracle
dxp123
范特西
大力的冬萱
认真的不评
猪猪hero
whisper
嘻嘻哈哈
Astraeus
YifanWang
俭朴书桃
火星上的菲鹰
MchemG
Ans
皖公网安备34019202002308
